Conversion factors to estimate effective doses from kerma area product in interventional cardiology. Impact of added filtration.
There is a large variation in the factors used to estimate effective doses from kerma area product (KAP) for interventional cardiology. These factors are required to estimate population doses. This paper presents the results for this conversion factor for cardiac procedures using tissue weighting factors of ICRP-103 and the impact of the added copper filtration in the X-ray beam. The data from 925 cardiac procedures and 75,347 radiation events were collected from two angiography laboratories using the DICOM Radiation Dose Structured Reports (RDSR). Effective doses were calculated with Monte Carlo software and the dosimetric, technical and geometrical information included in the RDSR. In one laboratory, with an X-ray system without Cu filtration for the cine runs, a factor of 0.21 ± 0.05 mSv/(Gy·cm2) was obtained. In other laboratory, incorporating a patient dose reduction technique, and 0.4 mm of Cu filtration for cine runs, the conversion factor was 0.29 ± 0.05 mSv/(Gy·cm2). The analysis of the radiation events for the different Cu filtrations (0.0; 0.1; 0.4 and 0.9 mm) resulted in conversion factors of: 0.16; 0.27; 0.34 and 0.40 mSv/(Gy·cm2) respectively. The estimation of effective and population doses from KAP should take into account the Cu filtration in the X-ray beam. For the X-ray system with patient dose reduction technique, using 0.4 mm Cu for cine runs, the global conversion factor increased by 38%, from 0.21 to 0.29 mSv/(Gy·cm2) in comparison to the standard X-ray system with a protocol that did not include copper filtration for cine acquisitions.